Katrin E. Rhodes - Concepedia

Author

Katrin E. Rhodes

University of Southern California

Also Known As

K. E. Rhodes, K. Rhodes, Katrin E Rhodes, Katrin E. Rhodes, Katrin Rhodes

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of Southern California University of California, Los Angeles Harvard Stem Cell Institute Broad Center Howard Hughes Medical Institute

About

Katrin E. Rhodes is an author at University of Southern California specializing in medicine, cell biology, and colorectal cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	756
2	Cell Biology	4	4	650
3	Health Sciences	2	2	323
4	Immunology	2	2	305
5	Molecular Genetics	1	1	40

Katrin E. Rhodes

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
The Emergence of Hematopoietic Stem Cells Is Initiated in the Placental Vasculature in the Absence of Circulation Katrin E. Rhodes, Christos Gekas, Yanling Wang, Cell stem cell Developmental BiologyPlacental DevelopmentMedicineStem Cell MobilizationHematology	2008	312
Reprogrammed Mouse Fibroblasts Differentiate into Cells of the Cardiovascular and Hematopoietic Lineages Katja Schenke‐Layland, Katrin E. Rhodes, Ekaterini Angelis, Stem Cells Transcription Factors Oct4ImmunologyCardiac Progenitor CellsCardiac RegenerationCell Differentiation	2008	239
Molecular Determinants of Cetuximab Efficacy Daniel Vallböhmer, Wu Zhang, Michael A. Gordon, Journal of Clinical Oncology	2005	234
Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab Anne M. Schultheis, Georg Lurje, Katrin E. Rhodes, Clinical Cancer Research	2008	184
Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab Wu Zhang, Michael A. Gordon, Oliver W. Press, Pharmacogenetics and Genomics	2006	111
Collagen IV Induces Trophoectoderm Differentiation of Mouse Embryonic Stem Cells Katja Schenke‐Layland, Ekaterini Angelis, Katrin E. Rhodes, Stem Cells	2007	109
Epidermal Growth Factor Receptor Gene Polymorphisms Predict Pelvic Recurrence in Patients with Rectal Cancer Treated with Chemoradiation Wu Zhang, Jae‐Hyun Park, Bo Lü, Clinical Cancer Research Gastrointestinal OncologyOncogenic AgentMedicineCancer RecurrenceRectal Cancer Treated	2005	88
ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia Deepa Shankar, Junling Li, Paul Tapang, Blood	2007	84
Gene Polymorphisms of Epidermal Growth Factor Receptor and its Downstream Effector, Interleukin-8, Predict Oxaliplatin Efficacy in Patients with Advanced Colorectal Cancer Wu Zhang, Jan Stoehlmacher, Jae‐Hyun Park, Clinical Colorectal Cancer Predict Oxaliplatin EfficacyMedicineImmunologyPathologyColorectal Cancer	2005	66
Molecular determinants of irinotecan efficacy Daniel Vallböhmer, Syma Iqbal, Dongyun Yang, International Journal of Cancer	2006	66

Page 1